FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to internal diseases, and is intended for treatment cardiovascular disease treatment. Liraglutide is used to reduce the development of a major adverse cardiovascular event (MACE) in a human subject with type 2 diabetes and cardiovascular disease, which is administered in a therapeutically effective amount to a subject who needs it. The indicated MACE represents death due to cardiovascular disease, non-fatal myocardial infarction and non-fatal stroke.
EFFECT: reduces the development of MACE in a human subject with type 2 diabetes and cardiovascular disease.
13 cl, 11 tbl, 1 ex, 7 dwg
| Title |
Year |
Author |
Number |
| SEMAGLUTIDE IN CARDIOVASCULAR CONDITIONS |
2017 |
- Khansen, Oluf Kristian Khejberg
|
RU2768283C2 |
| COMPOSITIONS AND METHODS FOR REDUCING SERIOUS ADVERSE CARDIOVASCULAR EVENTS |
2014 |
- Klassen Preston
- Tejlor Kristin
|
RU2711638C2 |
| RENIN-ANGIOTENSIN SYSTEM INHIBITORS APPLICATION FOR PREVENTING CARDIOVASCULAR DISEASE MANIFESTATIONS |
2000 |
- Shelkens Bernvard
- Bender Norbert
- Rangoonvala Badrudin
- Jusuf Salim
- Dazhene Zhill'
- Gershtajn Kherttsel'
|
RU2276997C2 |
| TREATMENT OF MYOCARDIAL INFARCTION WITH REGENERATED HIGH-DENSITY LIPOPROTEIN |
2017 |
- Wright, Samuel
- Shear, Charles
- D'Andrea, Denise
- Gille, Andreas
- Duffy, Danielle
|
RU2798830C2 |
| METHODS OF TREATING PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR DISEASES HAVING HYPERCHOLESTEROLEMIA |
2015 |
- Hanotin, Corinne
- Bessac, Laurence
- Chaudhari, Umesh
- Pordy, Robert
- Schwemmer Gipe, Daniel, A.
|
RU2723018C2 |
| GENETIC MARKERS FOR PREDICTING RESPONSE TO THERAPY BY RAISING HDL LEVEL OR IMITATING HDL AGENTS |
2015 |
- Dyube Mari-Per
- Tardif Zhan-Klod
|
RU2703192C2 |
| APPLICATION OF PYRAZOLE DERIVATIVE IN TREATMENT OF ACUTE ATTACKS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2013 |
|
RU2625762C2 |
| METHOD OF TREATING OR PREVENTING ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH MYOCARDIAL INFARCTION IN PAST HISTORY |
2016 |
- Stori Robert
- Andersson Magnus
- Andersson Tomas
- Bengtsson Olof
- Geld Peter
- Jensen Eva
- Khauells Garnet
|
RU2707959C2 |
| COMPOSITIONS AND METHODS FOR CARDIAC FAILURE TREATMENT |
2012 |
|
RU2646481C2 |
| USE OF LEVOCETIRIZINE AND MONTELUKAST IN TREATMENT OF TRAUMATIC INJURY |
2014 |
|
RU2672871C2 |
